 |
||
|
|
Hypertension Diagnostics Announces FY 2008 First Quarter Results
ST. PAUL, MN –
November 14, 2007 –
Hypertension Diagnostics, Inc. (OTC: HDII.OB), today announced financial
results for the first quarter of fiscal year 2008 ended September 30,
2007. Revenue for the quarter totaled $146,352 compared to $422,485 in
the prior year’s first quarter ended September 30, 2006, a 65.4%
decrease. The Company incurred a net loss of $456,208 for the current
quarter or $(.01) per share compared with a net loss of $188,081 for the
prior year’s quarter or $(.00) per share. Included in the net loss of
$456,208 for the quarter are total non-cash charges (expenses associated
mainly with stock compensation, depreciation, stock options) of
$316,976. Included in the net loss of $188,081 for the prior year’s
first quarter were non-cash charges of $87,206. The Company reported a
cash balance of $1,467,575 on September 30, 2007, an increase from
$1,376,632 reported on June 30, 2007. |
|
|
Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2006 Annual Report on Form 10-KSB, and subsequent Quarterly Reports on 10-QSB, all of which were filed with the U.S. Securities and Exchange Commission, as well as others not now anticipated.
CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved.
Website: www.HDII.com Return to the Main HDI Newsroom 
|
||
|
Copyright © 2007 Hypertension Diagnostics, Inc |
||
